nevirapine and enfuvirtide

nevirapine has been researched along with enfuvirtide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Decker, JM; Derdeyn, CA; Hunter, E; O'Brien, WA; Ratner, L; Sfakianos, JN; Shaw, GM; Zhang, Z	1
Back, DJ; Else, LJ; Khoo, SH; Taylor, S	1

Reviews

2 review(s) available for nevirapine and enfuvirtide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid). Antiviral therapy, 2011, Volume: 16, Issue:8 Topics: Adenine; Adult; Amniotic Fluid; Anti-HIV Agents; Cyclohexanes; Enfuvirtide; Female; Fetal Blood; Fetus; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Maraviroc; Nevirapine; Organophosphonates; Peptide Fragments; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Tenofovir; Triazoles; Viral Load; Zidovudine	2011

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).

Antiviral therapy, 2011, Volume: 16, Issue:8

Topics: Adenine; Adult; Amniotic Fluid; Anti-HIV Agents; Cyclohexanes; Enfuvirtide; Female; Fetal Blood; Fetus; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Maraviroc; Nevirapine; Organophosphonates; Peptide Fragments; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Tenofovir; Triazoles; Viral Load; Zidovudine

2011

Other Studies

1 other study(ies) available for nevirapine and enfuvirtide

Article	Year
Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor. Journal of virology, 2001, Volume: 75, Issue:18 Topics: Amino Acid Sequence; Anti-HIV Agents; Cell Line; Enfuvirtide; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV-1; Humans; Molecular Sequence Data; Nevirapine; Peptide Fragments; Receptors, CCR5; Receptors, CXCR4; Reverse Transcriptase Inhibitors	2001

Article

Year

Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.

Journal of virology, 2001, Volume: 75, Issue:18

Topics: Amino Acid Sequence; Anti-HIV Agents; Cell Line; Enfuvirtide; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV-1; Humans; Molecular Sequence Data; Nevirapine; Peptide Fragments; Receptors, CCR5; Receptors, CXCR4; Reverse Transcriptase Inhibitors

2001